Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Datametrex AI Ltd V.DM

Alternate Symbol(s):  DTMXF

Datametrex AI Limited is a technology-focused company with verticals in industries, including artificial intelligence, machine learning, and healthcare. Its products include AnalyticsGPT, Cyber Security, and Healthcare. AnalyticsGPT platform scans vast data streams from social media, news, blogs, forums, messengers, enterprise data, and dark Web, making predictive analytics. This platform provides insights into market trends and direct customer feedback. Cyber Security is a deep analytics platform that captures, structures, and visualizes vast amount of unstructured social media data, which is used as a discovery tool that allows organizations to make decisions. It offers Nexa Products, which consists of NexaSecurity and NexaSMART. Healthcare consists of Imagine Health Centres, a multidisciplinary healthcare facility, and Medi-Call, a telehealth platform.


TSXV:DM - Post by User

Comment by rollthedice10on Nov 10, 2023 5:47pm
121 Views
Post# 35729548

RE:RE:The difference in the MD&A

RE:RE:The difference in the MD&A
RazeKreations wrote:

Old Statement

Summary of Recent Developments

 

The Company announced the Normal Course Issuer Bid program to increase value for shareholders. For the year ending

December 31, 2022, the Company has purchased a total of 21,594,000 shares in 2022 through the NCIB share buyback

program.

 

New Statement

Summary of Recent Developments

NCIB Share Buyback Program

 

For the three months ended March 31, 2023, the Company has purchased a total of 12,604,000 common shares of the

Company for an aggregate amount of $1,210,677 through the NCIB share buyback program. During the period, a total

of 16,390,500 common shares were returned to treasury and cancelled.

 

Summary of NCIB Share Buyback Program

 

In 2022, the Company spent $2,040,650.71 to cancel 17,807,500 shares.

 



I definitely prefer the " new " version. I have to agree with other posters that this will be a welcome change. More detail and transparency is what a lot of shareholders have been asking for. Sure, they are very busy but thin
MD&A does not help anyone. I see this as a positive going forward. Maybe it will help quiet the bashers, but I doubt it. For the OSC to actually have a look amazes me. They must have received complaints. In this case, it is a positive for shareholders and will only make DM look more professional.
Staying long and strong!
<< Previous
Bullboard Posts
Next >>